Advancing eye care for our community through clinical research
We are proud to take part in research that helps shape the future of ophthalmology. Through clinical trials, our team helps bring promising new treatments closer to patients who need them.
Every participant makes a difference – your involvement helps researchers understand new therapies and may open the door to better treatment options for others.
Current Recruiting Trials
Metagone (Implant for Geographic Atrophy)
- This is a Phase 1/2a study to evaluate the safety, tolerability and efficacy after one-time intravitreal implant administration of TO-O1007 in participants.
- Study duration: 28 weeks
Upcoming Trials
Malbec (Injection for Wet AMD)
- This is a Phase 2/3 study to evaluate the efficacy and safety of intravitreal EYE201/MK-8748 compared to Aflibercept 2 mg in participants with neovascular age-related macular degeneration.
- Study Duration: 2 years
CA201A — Eye Drops for Cataract Surgery Recovery
- A Phase 2 study evaluating the safety and efficacy of CA201A eye drops compared with a vehicle-controlled, for the prevention of corneal endothelial cell loss in participants undergoing cataract surgery.
- Study duration: 12 weeks
Interested in Participating?
Contact our team to find out if you may be eligible for one of our trials.
Contact us: reception@launcestoneyedoctors.com.au | Phone: 03 6334 0000
